High-Frequency Chest-Wall Oscillation Devices Market Report 2024

The high-frequency chest-wall oscillation devices market size has grown strongly in recent years. It will grow from $2.29 billion in 2023 to $2.47 billion in 2024 at a compound annual growth rate (CAGR) of 7.7%. During the historical period, growth was driven by rising incidences of respiratory diseases, an aging population, increased awareness and diagnosis rates, higher disposable incomes, and an uptick in respiratory conditions.

The high-frequency chest-wall oscillation devices market size is expected to see strong growth in the next few years. It will grow to $3.34 billion in 2028 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to the growing number of COPD patients, heightened awareness of airway clearance therapy benefits, increased research and development investments, growing recognition of HFCWO device advantages, and a rising elderly population. Emerging trends include expanded research endeavors, the adoption of wearable HFCWO devices, incorporation of smart technology, a shift towards home healthcare and telehealth services, and a heightened focus on pediatric care.

The increasing prevalence of chronic obstructive pulmonary diseases (COPD) is expected to drive growth in the high-frequency chest wall oscillation (HFCWO) devices market. COPD, a progressive lung disease characterized by persistent respiratory symptoms and airflow limitation, is primarily caused by factors such as smoking, environmental pollutants, genetic predisposition, and an aging population. HFCWO devices play a crucial role in managing COPD by mobilizing and clearing mucus from the airways, thereby reducing infection risks, improving lung function, and enhancing patient comfort. For example, according to the Scottish Public Health Observatory, COPD rates have been rising post-COVID-19, with noticeable increases in both male (from 83.2 to 97.6 cases per 100,000) and female (from 72.6 to 97.3 cases per 100,000) populations. Therefore, the growing prevalence of COPD is a key driver behind the expansion of the high-frequency chest wall oscillation (HFCWO) devices market.

Leading companies in the HFCWO devices market are focusing on developing programmable air pulse generators to customize treatments and improve patient comfort. These generators deliver controlled air pulses at adjustable frequencies and intensities, aiding in mucus mobilization and airway clearance for conditions such as cystic fibrosis and bronchiectasis. For instance, in November 2023, Electromed Inc., a US-based company specializing in airway clearance devices, launched the fifth-generation SmartVest Clearway system. This system utilizes HFCWO therapy, delivering alternating air pulses through a vest garment that compresses and releases the chest wall to oscillate airflow within the airways. The SmartVest Clearway system is designed to provide therapeutic relief for patients with conditions requiring effective airway clearance therapy, including those with muscle weakness, impaired cough, or compromised ventilation.

In December 2021, Baxter International, a US-based healthcare company, completed the acquisition of Hillrom Holdings Inc. for $10.5 billion. This strategic move enabled Baxter to enhance its digital health and connected care capabilities by integrating Hillrom's advanced digital health technologies with Baxter's existing portfolio. Hillrom Holdings Inc., based in the US, specializes in medical technology, particularly known for its mobile high-frequency chest wall oscillation (HFCWO) therapy.

Major companies operating in the high-frequency chest-wall oscillation devices market are F. Hoffmann-La Roche AG, Medtronic plc, Becton, Dickinson and Company, Koninklijke Philips N.V., Baxter International Inc., Medline Industries LP., Hill-Rom Holdings Inc., Teleflex Incorporated, Lincare Holdings Inc., Tactile Medical, Vapotherm Inc., Aerogen, Electromed Inc., Trudell Medical International, Monaghan Medical Corporation, Hayek Medical, Ventec Life Systems, Respinova Ltd., PARI Medical Holding GmbH, Drägerwerk AG & Co. KGaA.

North America was the largest region in the high-frequency chest-wall oscillation devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the high-frequency chest-wall oscillation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the high-frequency chest-wall oscillation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

High-frequency chest-wall oscillation (HFCWO) devices are medical instruments utilized for airway clearance therapy. They administer external mechanical vibrations to the chest wall, facilitating the mobilization and elimination of lung mucus.

The primary types of HFCWO devices encompass AffloVest, vest-type devices such as SmartVest and RespirTech. AffloVest, a battery-operated HFCWO device, permits patients to maintain full mobility during airway clearance treatments. These devices incorporate technologies such as percussion, compression, and vibration, tailored to diverse patient groups including pediatric, adult, and geriatric populations. They find applications in various settings including clinics, hospitals, and other healthcare facilities.

The high-frequency chest-wall oscillation devices market research report is one of a series of new reports that provides high-frequency chest-wall oscillation devices market statistics, including the high-frequency chest-wall oscillation devices industry global market size, regional shares, competitors with high-frequency chest-wall oscillation devices market share, detailed high-frequency chest-wall oscillation devices market segments, market trends, and opportunities, and any further data you may need to thrive in the high-frequency chest-wall oscillation devices industry. These high-frequency chest-wall oscillation devices market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The high-frequency chest-wall oscillation devices market consists of revenues earned by entities by providing services such as device manufacturing and sales, rental and leasing, maintenance and repair, clinical training and support, and patient education programs. The market value includes the value of related goods sold by the service provider or included within the service offering. The high-frequency chest-wall oscillation devices market also includes sales of accessories and consumables such as vests, hoses, connectors, and replacement parts. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.